Benzinga’s News Roundup (RGS, CNC, BA, SSRX, BCRX, BCS)
January 08, 2010 8:39 AM
Regis Corporation (NYSE: RGS) today reported a second-quarter revenue of $575 million as compared to $587 million in the year ago period. Analysts on an average had expected Regis to report revenues of $581.6 million for the second quarter. In the previous trading session, RGS closed at $16.35. Regis has surged over 30% in the last six months.
Centene Corporation (NYSE: CNC announced today that for fiscal 2010, it expects premium and service revenue to be between $4.35 - $4.45 billion and earnings per diluted share (EPS) to be in the range of $1.90 - $2.00. Analysts were expecting Centene to report EPS of $1.96 on revenue of $4.51 billion for the same period. CNC closed at $21.79 in the last trading session. The 52-week trading range for Centene is $15.00 - $22.50. In the last year, Centene has gained over 10%.
The Boeing Company (NYSE: BA) was downgraded today by Macquarie Equities Research from Hold to Neutral but price target increased from $60 to $66. Boeing declined 0.34% to $61.99. BA made a new 52-week high yesterday at $62.31. In the last year, BA has gained over 37%.
3SBio Inc. (ADR) (NASDAQ: SSRX) announced today that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration (SFDA) for Feraheme Injection. In the last trading session, SSRX closed at $13.23. The 52-week trading range for SSRX is $4.18 - $14.45.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) announced today that its partner, Green Cross, has filed a New Drug Application (NDA) in South Korea to seek regulatory approval for intravenous peramivir to treat patients with influenza. BioCryst Pharmaceuticals closed at $7.49 in the previous trading session. In the last six months, BCRX has surged over 90%.
Barclays PLC (ADR) (NYSE: BCS) was upgraded today by UBS from Neutral to Buy. Barclays surged 2.30% to $20.87 in the pre-market session. The 52-week trading range for BCS is $2.75 - $25.68. In the last trading session, BCS closed at $20.40.
